Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

11/09/10 Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drug.        

11/08/10 IsoRay Awarded More Than $526,000 in Federal Grants for Breast, Brain and Lung Cancer        

11/08/10 New trial: A Phase I Trial of Lenalidomide and Radiotherapy in Children With Diffuse Intrinsic Pontine Gliomas and High-Grade Gliomas        

11/05/10 Cedars-Sinai "Nano-Drug" Hits Brain-Tumor Target Found In 2001        

10/30/10 Combined use of neuroradiology and (1)H-MR spectroscopy may provide an intervention limiting diagnosis of glioblastoma multiforme.        

10/30/10 Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.        

10/30/10 FDA approves Afinitor for brain tumor treatment        

10/30/10 IBTA E News October 2010        

10/29/10 Targeted therapy for high-grade glioma with the TGF-{beta}2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.        

10/26/10 National Brain Tumor Society - Free live Q & A session on ependymoma tumors        

10/24/10 Oncomodulation by human cytomegalovirus: novel clinical findings open new roads.        

10/22/10 SUBGROUP AND QUALITY OF LIFE ANALYSES OF THE PHASE III CLINICAL TRIAL OF NOVOTTF-100A VERSUS BEST STANDARD CHEMOTHERAPY FOR RECURRENT GLIOBLASTOMA [Abstracts from SNO]        

10/22/10 NO-56. NEW TREATMENT FOR RADIATION NECROSIS OF THE BRAIN        

10/22/10 U.S. Blockade Doubly Hurts Cuban Cancer Patients        

10/22/10 NO-54. MODELING TUMOR GROWTH KINETICS AND ITS IMPLICATIONS FOR TTFIELDS TREATMENT PLANNING [Abstracts From SNO 2010]        

10/22/10 Abstracts From Society For Neuro-oncology 2010 Annual Meeting!        

10/22/10 New Clinical Study for Recurrent Glioblastoma Being Conducted at City of Hope: Neural Stem Cell Platform: First-In-Human Trials        

10/21/10 Exiqon subsidiary Oncotech goes out of business — irresponsibly        

10/20/10 Brain Tumor Non Profit is a Top Ten Finalist for Charity of the Year [Editor's Note: This organization was one of the cofounders of the Grey Ribbon Crusade with us - they are a good group and please vote for them!]        

---

Displaying Stories 2881 to 2900 of 7673
Previous 20           Next 20